Suchergebnisse - "*Coronaviridae"

PubPharm (269)

1

SARS-CoV-2 Main Protease Inhibitors from Natural Product Repository as Therapeutic Candidates for the Treatment of Coronaviridae Infections

enthalten in: Current medicinal chemistry | 2023

von Khanfar, M. | Saleh, M.

2

SARS-CoV-2 helicase might interfere with cellular nonsense-mediated RNA decay : insights from a bioinformatics study

enthalten in: BMC genomic data | 2023

von Akbari, B. | Ahmadi, E. | Zabihi, M. | +3

3

SARS-CoV-2 helicase might interfere with cellular nonsense-mediated RNA decay: insights from a bioinformatics study

enthalten in: BMC genetics | 2023

von Akbari, B. | Ahmadi, E. | Zabihi, M. | +3

4

Heberon Alfa R in COVID-19 : Use of Heberon® Alfa R in patients confirmed for infection with SARS-CoV-2 in Cuba. Observational clinical study. (COVID-19)

enthalten in: WHO International Clinical Trials Registry Platform | 2023

5

Biomodulina T - IM - covid-19 - older adult : Evaluation of the efficacy and safety of a new BIOMODULINA T® dosage scheme for the prevention of infections, including COVID-19, in older adults in Cuba. Confirmatory study (COVID-19)

enthalten in: WHO International Clinical Trials Registry Platform | 2023

6

Exploratory study of BMT EV to stimulate immune response in patients with CKD-5 on iterated hemodialysis : Evaluation of the effect and safety of BIOMODULIN T® for the stimulation of the immune response in patients with Stage 5 Chronic Kidney Disease under an iterated hemodialysis regimen. Exploratory study. (COVID-19)

enthalten in: WHO International Clinical Trials Registry Platform | 2023

7

ATENEA-Co-300 study : Application of the CIGB 300 as Antiviral in the treatment of patients with a diagnosis of Covid 19. (COVID-19)

enthalten in: WHO International Clinical Trials Registry Platform | 2023

8

SOBERANA 02 : Phase I study, open, sequential and adaptive for evaluating the safety, reactogenicity and explore the immunogenicity of the prophylactic Vaccine Candidate FINLAY-FR-2 anti SARS-CoV-2 (COVID-19) - SOBERANA 02

enthalten in: WHO International Clinical Trials Registry Platform | 2023

9

Prevalence of positive evolutive PCR in patients with COVID 19 treated with rectal ozone therapy: observational study prospective cohort. : Prevalence of positive evolutive PCR in patients with COVID 19 treated with rectal ozone therapy: observational study prospective cohort. (COVID-19) - OZONOTHERAPY-STUDY-OBSERVACIONAL

enthalten in: WHO International Clinical Trials Registry Platform | 2023

10

MAMBISA Study : Adaptive phase I / II clinical trial, randomized, of parallel groups, to evaluate the safety and immunogenicity in adults of two vaccine candidates, based on recombinant RBD subunits for the prevention of COVID-19 in regimens that use the nasal route of administration. (COVID-19)

enthalten in: WHO International Clinical Trials Registry Platform | 2023

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]